Product-focused R&D technology leader with the ability to conceive, develop and optimize complex molecular assays at the interface of biology, microfluidics, optics, chemistry, hardware, and ML. Listed as an inventor on over 100 patents, numerous peer-reviewed publications, and a book chapter. Worked closely with 10X senior leadership to scope and evaluate new opportunities, which led to three M&As totaling $487 Million (Spatial Transcriptomics, Sweden, 38.6M, CartaNA, Sweden, $41.8M, Readcoor, Cambridge, MA, 407.4M).